Abstract
Dietary fiber intake is associated with lower incidence and mortality from disease, but the underlying mechanisms of these protective effects are unclear. We hypothesized that β2→1-fructan dietary fibers confer protection on intestinal epithelial cell barrier function via Toll-like receptor 2 (TLR2), and we studied whether β2→1-fructan chain-length differences affect this process. T84 human intestinal epithelial cell monolayers were incubated with 4 β2→1-fructan formulations of different chain-length compositions and were stimulated with the proinflammatory phorbol 12-myristate 13-acetate (PMA). Transepithelial electrical resistance (TEER) was analyzed by electric cell substrate impedance sensing (ECIS) as a measure for tight junction-mediated barrier function. To confirm TLR2 involvement in barrier modulation by β2→1-fructans, ECIS experiments were repeated using TLR2 blocking antibody. After preincubation of T84 cells with short-chain β2→1-fructans, the decrease in TEER as induced by PMA (62.3 ± 5.2%, P < 0.001) was strongly attenuated (15.2 ± 8.8%, P < 0.01). However, when PMA was applied first, no effect on recovery was observed during addition of the fructans. By blocking TLR2 on the T84 cells, the protective effect of short-chain β2→1-fructans was substantially inhibited. Stimulation of human embryonic kidney human TLR2 reporter cells with β2→1-fructans induced activation of nuclear factor kappa-light-chain-enhancer of activated B cells, confirming that β2→1-fructans are specific ligands for TLR2. To conclude, β2→1-fructans exert time-dependent and chain length-dependent protective effects on the T84 intestinal epithelial cell barrier mediated via TLR2. These results suggest that TLR2 located on intestinal epithelial cells could be a target of β2→1-fructan-mediated health effects.
© 2014 American Society for Nutrition.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Inflammatory Agents, Non-Steroidal / antagonists & inhibitors
-
Anti-Inflammatory Agents, Non-Steroidal / chemistry
-
Anti-Inflammatory Agents, Non-Steroidal / metabolism*
-
Antibodies, Blocking / pharmacology
-
Cell Line
-
Colon / drug effects
-
Colon / immunology
-
Colon / metabolism*
-
Diglycerides / pharmacology
-
Fructans / antagonists & inhibitors
-
Fructans / chemistry
-
Fructans / metabolism*
-
Gastrointestinal Agents / antagonists & inhibitors
-
Gastrointestinal Agents / chemistry
-
Gastrointestinal Agents / metabolism
-
Humans
-
Intestinal Mucosa / drug effects
-
Intestinal Mucosa / immunology
-
Intestinal Mucosa / metabolism*
-
Kidney / drug effects
-
Kidney / immunology
-
Kidney / metabolism
-
Ligands
-
Membrane Transport Modulators / antagonists & inhibitors
-
Membrane Transport Modulators / toxicity
-
Molecular Structure
-
NF-kappa B / agonists
-
NF-kappa B / metabolism
-
Oligopeptides / pharmacology
-
Prebiotics / analysis
-
Protective Agents / chemistry
-
Protective Agents / metabolism*
-
Recombinant Proteins / chemistry
-
Recombinant Proteins / metabolism
-
Tetradecanoylphorbol Acetate / analogs & derivatives
-
Tetradecanoylphorbol Acetate / antagonists & inhibitors
-
Tetradecanoylphorbol Acetate / toxicity
-
Tight Junctions / drug effects
-
Tight Junctions / immunology
-
Tight Junctions / metabolism*
-
Toll-Like Receptor 2 / agonists*
-
Toll-Like Receptor 2 / antagonists & inhibitors
-
Toll-Like Receptor 2 / genetics
-
Toll-Like Receptor 2 / metabolism
-
Transcription Factor AP-1 / agonists
-
Transcription Factor AP-1 / metabolism
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antibodies, Blocking
-
Diglycerides
-
FSL-1 lipoprotein, synthetic
-
Fructans
-
Gastrointestinal Agents
-
Ligands
-
Membrane Transport Modulators
-
NF-kappa B
-
Oligopeptides
-
Prebiotics
-
Protective Agents
-
Recombinant Proteins
-
TLR2 protein, human
-
Toll-Like Receptor 2
-
Transcription Factor AP-1
-
phorbolol myristate acetate
-
Tetradecanoylphorbol Acetate